{"product_id":"at-ahip-a-tale-of-two-farces-portland-and-price-transparency","title":"At AHIP — A Tale of Two Farces, Portland, and  Price Transparency","description":"\u003cp\u003eAt AHIP — A Tale of Two Farces, Portland, and  Price Transparency\u003cbr\u003e\nThis IDC Market Perspective discusses price transparency at AHIP and in the healthcare industry.\"One year in, the industry should take a pause and reflect on the fiction that is executing. Price transparency has snowballed from a politician's talking point to legislation to regulation to an expensive, ongoing administrative facade,\" states Jeff Rivkin, research director, IDC Health Insights. \"The exchanged data is seriously flawed, and even if the data was good, the vast majority of consumers do not have the time, money, patience, medical literacy, or desire to actually shop for procedures. Similarly, payer-provider contract negotiations based on inaccurate, non-standard product, network, and rate data are an equivalent absurdity.\"\u003c\/p\u003e\n\n\u003cp\u003ePlease Note: Extended description available upon request.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"August, 2023 \/ 7 Pages \/ MCW16242249","offer_id":47662059127090,"sku":null,"price":5400.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/at-ahip-a-tale-of-two-farces-portland-and-price-transparency","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}